New approach to starting addiction treatment avoids withdrawal
NCT ID NCT05118204
First seen Nov 01, 2025 · Last updated Jun 09, 2026 · Updated 31 times
Summary
This study tested a new method of starting buprenorphine (a medication for opioid use disorder) that avoids the usual withdrawal symptoms. Participants were adults with opioid misuse and chronic pain who were already taking opioids. The study compared starting with tiny doses of buprenorphine while continuing other opioids versus the standard approach of stopping opioids first. The trial was terminated early with only 23 participants enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
Conditions
Explore the condition pages connected to this study.